Mecetronium chloride | 13264-41-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Mecetronium chloride
• 英文别名: ethyl-hexadecyl-dimethylazanium;chloride
• CAS: 13264-41-0
• 化学式: C20H44ClN
• 分子量: 334.0
• InChiKey: KSCHLNBLIAOANF-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3.57
• 重原子数：
  22
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2923900090

文献信息

• Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
  申请人：——

  公开号：US20020106325A1

  公开（公告）日：2002-08-08

  The present invention describes a method of concurrent imaging in a mammal comprising: a) administering to said mammal a vitronectin receptor targeted imaging agent and a perfusion imaging agent; and b) concurrently detecting the vitronectin target imaging agent bound at the vitronectin receptor and the perfusion imaging agent; and c) forming an image from the detection of said vitronectin receptor targeted imaging agent and said perfusion imaging agent.

  本发明描述了一种在哺乳动物中进行并行成像的方法，包括： a) 向所述哺乳动物施用一个靶向维龙蛋白受体的成像剂和一个灌注成像剂；以及 b) 同时检测维龙蛋白靶向成像剂与维龙蛋白受体结合以及灌注成像剂；以及 c) 从检测到的维龙蛋白受体靶向成像剂和灌注成像剂形成图像。
• Process for the preparation cyano carboxylic acid esters
  申请人：Lonza Ltd

  公开号：EP2455365A1

  公开（公告）日：2012-05-23

  The present invention relates to a process for the preparation of a cyano carboxylic acid ester of the formula wherein R1 is a linear or branched C1-8 alkanediyl group; and R2 is a linear or branched alkyl group, a cycloalkyl group, or an aryl or arylalkyl group, wherein aryl is optionally substituted with one or more C1-8 alkyl groups; comprising reacting a halo carboxylic acid ester of the formula wherein R1 and R2 are as defined above; and Hal is fluorine, chlorine, bromine or iodine; in a reaction mixture comprising a homogeneous liquid phase, wherein the liquid phase consists of water and an organic solvent, with an alkali metal cyanide in the presence of hydrogen cyanide, optionally in the presence of a catalyst, to obtain the cyano carboxylic acid ester of the formula (I).

  本发明涉及一种制备氰基羧酸酯的过程，其化学式为其中R1是直链或支链的C1-8烷二基基团；R2是直链或支链的烷基团、环烷基团或芳基或芳基烷基团，其中芳基可以选择性地与一个或多个C1-8烷基团取代；包括在反应混合物中反应化学式为的卤代羧酸酯其中R1和R2如上定义；Hal是氟、氯、溴或碘；在包含均相液相的反应混合物中，液相由水和有机溶剂组成，与碱金属氰化物在氢氰的存在下反应，可选地在催化剂的存在下，以获得化学式（I）的氰基羧酸酯。
• Process for producing allyl halide compound
  申请人：——

  公开号：US20020107422A1

  公开（公告）日：2002-08-08

  There are disclosed a composition comprising (E)-1,4-dibromo-2-methyl-2-butene and (Z)-1,4-dibromo-2-methyl-2-butene, wherein the ratio of the E isomer to the total amount of the E and Z isomers is 0.9 or more; a process for producing the same and a process using the same to produce an allyl halide compound of formula (1): 1 wherein X denotes a bromine atom, Y denotes an ArS(O) 2 group or an RCOO group, wherein Ar denotes an aryl group which may be substituted and R denotes a hydrogen atom, a lower alkyl group or an aryl group which may be substituted, and the wavy line means that the derivative is a mixture of an E or Z geometrical isomer.

  本发明涉及一种包含(E)-1,4-二溴-2-甲基-2-丁烯和(Z)-1,4-二溴-2-甲基-2-丁烯的组合物，其中E异构体与E和Z异构体的总量之比为0.9或更高；一种生产该组合物的方法以及使用该组合物生产化合物的方法，所述化合物的分子式为（1）：其中X代表溴原子，Y代表ArS(O)2基团或RCOO基团，其中Ar代表可能被取代的芳基，R代表氢原子、低碳烷基或可能被取代的芳基，波浪线表示衍生物是E或Z几何异构体的混合物。
• Diagnostic Agents Selective Against Metalloproteases
  申请人：Bracco Imaging S.p.A

  公开号：EP2147684A1

  公开（公告）日：2010-01-27

  The invention relates to aryl-sulphonamido compounds endowed with affinity against metallo proteases MMP, having formula (I) below wherein R, R1, R2, R3, G and n have the meanings reported in the specification, properly labelled with diagnostic imaging moieties or even radiotherapeutic moieties. The invention also refers to the process for their preparation, to pharmaceutical compositions comprising them and to their use as diagnostic imaging agents or radiotherapeutic agents.

  本发明涉及具有亲和力对金属蛋白酶MMP的芳基磺酰胺化合物，其化学式如下（I），其中R，R1，R2，R3，G和n在规范中有所说明，适当地标记有诊断成像或放射治疗成分。本发明还涉及它们的制备过程、包含它们的药物组成物以及它们作为诊断成像剂或放射治疗剂的用途。
• SULFONE COMPOUND AND CAROTENOID MANUFACTURING METHOD USING SAID COMPOUND
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP2253613A1

  公开（公告）日：2010-11-24

  The present invention relates to a process for producing a sulfone compound of the following formula (3), characterized in that an allyl sulfone compound of the formula (1) and an allyl halide compound of the formula (2) are reacted in an organic solvent in the presence of an alkali metal hydroxide and a phase-transfer catalyst: wherein A is CH2 or C=O; Ar is an aryl group optionally having 1 to 3 substitutents; and the wavy line means that the steric relation to the double bond which the wavy line is bound to is of E-form, Z-form or a mixture of E/Z; wherein X is a halogen atom; and the wavy line means the same as defined above; and wherein A, Ar and the wavy line mean the same as defined above. The present invention also relates to a process for producing a carotenoid from the same sulfone compound.

  本发明涉及一种生产以下式（3）的砜化合物的方法，其特征在于，在有机溶剂中，在碱金属氢氧化物和相转移催化剂的存在下，反应式（1）的烯丙基砜化合物和反应式（2）的烯丙基卤化物化合物：其中A是CH2或C=O; Ar是一个芳基团，可选地具有1至3个取代基; 波浪线表示与波浪线所绑定的双键的立体关系为E形式、Z形式或E/Z的混合物;其中X是卤素原子; 波浪线的含义与上述定义相同; 其中A、Ar和波浪线的含义与上述定义相同。本发明还涉及从该砜化合物生产类胡萝卜素的方法。